POPULARITY
Categories
218 episodes with md phd
86 episodes with md phd
156 episodes with md phd
160 episodes with md phd
140 episodes with md phd
206 episodes with md phd
142 episodes with md phd
64 episodes with md phd
75 episodes with md phd
65 episodes with md phd
78 episodes with md phd
40 episodes with md phd
64 episodes with md phd
46 episodes with md phd
36 episodes with md phd
47 episodes with md phd
43 episodes with md phd
46 episodes with md phd
46 episodes with md phd
25 episodes with md phd
67 episodes with md phd
35 episodes with md phd
38 episodes with md phd
50 episodes with md phd
16 episodes with md phd
36 episodes with md phd
23 episodes with md phd
24 episodes with md phd
41 episodes with md phd
43 episodes with md phd
21 episodes with md phd
34 episodes with md phd
10 episodes with md phd
38 episodes with md phd
9 episodes with md phd
26 episodes with md phd
20 episodes with md phd
21 episodes with md phd
15 episodes with md phd
16 episodes with md phd
13 episodes with md phd
25 episodes with md phd
6 episodes with md phd
15 episodes with md phd
20 episodes with md phd
22 episodes with md phd
11 episodes with md phd
10 episodes with md phd
12 episodes with md phd
8 episodes with md phd
8 episodes with md phd
7 episodes with md phd
9 episodes with md phd
6 episodes with md phd
8 episodes with md phd
15 episodes with md phd
5 episodes with md phd
4 episodes with md phd
14 episodes with md phd
5 episodes with md phd
10 episodes with md phd
13 episodes with md phd
8 episodes with md phd
6 episodes with md phd
20 episodes with md phd
6 episodes with md phd
5 episodes with md phd
5 episodes with md phd
8 episodes with md phd
6 episodes with md phd
5 episodes with md phd
6 episodes with md phd
4 episodes with md phd
8 episodes with md phd
5 episodes with md phd
6 episodes with md phd
7 episodes with md phd
5 episodes with md phd
4 episodes with md phd
11 episodes with md phd
5 episodes with md phd
10 episodes with md phd
19 episodes with md phd
6 episodes with md phd
5 episodes with md phd
4 episodes with md phd
6 episodes with md phd
9 episodes with md phd
6 episodes with md phd
5 episodes with md phd
4 episodes with md phd
15 episodes with md phd
5 episodes with md phd
5 episodes with md phd
5 episodes with md phd
5 episodes with md phd
12 episodes with md phd
4 episodes with md phd
5 episodes with md phd
4 episodes with md phd
4 episodes with md phd
16 episodes with md phd
6 episodes with md phd
3 episodes with md phd
5 episodes with md phd
4 episodes with md phd
3 episodes with md phd
6 episodes with md phd
4 episodes with md phd
12 episodes with md phd
3 episodes with md phd
4 episodes with md phd
5 episodes with md phd
4 episodes with md phd
4 episodes with md phd
2 episodes with md phd
2 episodes with md phd
2 episodes with md phd
4 episodes with md phd
4 episodes with md phd
10 episodes with md phd
2 episodes with md phd
4 episodes with md phd
3 episodes with md phd
3 episodes with md phd
9 episodes with md phd
4 episodes with md phd
68 episodes with md phd
3 episodes with md phd
3 episodes with md phd
3 episodes with md phd
4 episodes with md phd
4 episodes with md phd
2 episodes with md phd
2 episodes with md phd
Michael G. Fehlings MD, PhD, FRCSYi Lu, MD PhDRajiv Saigal, MD PhD
Dr. Wilner would love your feedback! Click here to send a text! Thanks!Many thanks to Rebecca Gilbert, MD, PhD, for joining me on Episode #166 of The Art of Medicine with Dr. Andrew Wilner. Dr. Gilbert is a movement disorders specialist at Bellevue Hospital in New York City and Chief Mission Officer of the American Parkinson's Disease Association. She trained at Memorial Sloan Kettering and Columbia University, where she studied under renowned movement disorders specialist Dr. Stanley Fahn. During our 35-minute conversation, Dr. Gilbert described the symptoms of Parkinson's disease and emphasized the importance of dopaminergic medications and regular exercise to improve quality of life. We also explored the intriguing and still unexplained observation that music can enhance movement in people with Parkinson's disease. Dr. Gilbert highlighted the new American Parkinson's Disease Association public service announcement launched for Parkinson's Awareness Month, “Do What You Do.” This campaign showcases people with Parkinson's who continue to pursue their passions despite the challenges of the disease. Finally, Dr. Gilbert reviewed recent advances in Parkinson's disease treatment, including adaptive deep brain stimulation and subcutaneous infusion pumps. She also discussed ongoing efforts to develop biomarkers that can diagnose the disease at an earlier stage. For more information about Parkinson's disease, please visit: www.support.apdaParkinson.org #Parkinsons @APDA @RebeccaGilbert #movementdisorders @theartofmedicine #dopamine #DBSPlease click "Fanmail" and share your feedback!If you enjoy an episode, please share with friends and colleagues. "The Art of Medicine with Dr. Andrew Wilner" is now available on Alexa! Just say, "Play podcast The Art of Medicine with Dr. Andrew Wilner!" To never miss a program, subscribe at www.andrewwilner.com. Follow me on Instagram: @andrewwilnermdX: @drwilnerlinkedin.com/in/drwilner Please rate and review each episode. To contact Dr. Wilner or to join the mailing list: www.andrewwilner.comThis production has been made possible in part by support from “The Art of Medicine's” wonderful sponsor, Locumstory.com, a resource where providers can get real, unbiased answers about locum tenens. If you are interested in locum tenens, or considering a new full-time position, please go to Locumstory.com.Or paste this link into your browser:https://locumstory.com/?source=DSP_directbuy_drwilnerpodcast...
Can The Short Coats make a card game that captures the twists and turns of medical school? Well, we've given it a try, and now we finally play it — the Game of Med School, a prototype card-based playthrough of the full medical school path, from premed clubs to residency match. Cyrus Barati, who helped build the game, takes on the Gunner identity and immediately gets routed to clinical years while still underwater on points. M4 Fallon Jung (pregnant, unbothered) draws the Resilient Student card and somehow converts a failed Step exam into a net positive. M3s Sarah Upton and Zach Grissom round out the cast, with Zach's Non-Traditional Student racking up an improbable collection of degrees, nursing licenses, and EMT certifications before anyone gets to medical school proper. The cards lead to real conversations: What's a post-bacc worth on an application? How do you handle a professionalism flag? What actually happens when your PI moves states mid-MD-PhD? How do you tell a patient bad news — and does a med student ever actually have to? Does your identity change any of that? The real question: would you play this game if we gave it away? Listener feedback is always welcome at https://theshortcoat.com/tellus!
This episode marks the 100th episode of The Chemical Sensitivity Podcast!Thank you very much to the Marilyn Brachman Hoffman Foundation for its support that makes this work possible.Gratitude to listeners and viewers around the world for being part of this journey. If you enjoy the podcast, please subscribe wherever you listen to podcasts and on YouTube, and share it with others who may benefit from these conversations.http://listen.chemicalsensitivitypodcast.org/Here's to 100 episodes and more to come!In this episode:What can the history of lead exposure teach us about risk, regulation, and MCS?Aaron Goodman speaks with Bruce Lanphear, MD, PhD, about lead as a model for understanding chemical harm.Topics include:What lead teaches us about body burden and cumulative exposureRisk, regulation, and the precautionary principleWhy listening to affected people matters—and lessons for MCSListen and subscribe: http://listen.chemicalsensitivitypodcast.org/Watch & subscribe on YouTube: https://www.youtube.com/@podcastingMCSLink: Dr. Bruce Lanphearhttps://www.sfu.ca/fhs/about/people/profiles/bruce-lanphear.htmlSupport the showThank you very much to the Marilyn Brachman Hoffman Foundation generously supporting the podcast!If you find the podcast helpful, please consider becoming a monthly or one-time supporter:https://www.chemicalsensitivitypodcast.org/1970633/supporters/newhttps://buymeacoffee.com/mcspodcast Follow the podcast on YouTube! Captions available in any language. Please follow the podcast on social media:FacebookInstagramXBlueSkyTikTok
How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, guest host Erin Schenk, MD, PhD, at the University of Colorado Anschutz in Aurora, an associate professor of medicine in the Division of Medical Oncology, sat down with D. Ross Camidge, MD, PhD, to highlight Dr Camidge's storied career and life. Driven by a relentless curiosity that often manifested in him "interrogating" those around him, Camidge chose a career in medicine because of the immediate effect he saw it could have on people's lives.His path included a formative gap year working at McDonald's and serving as a caregiver for a man with cerebral palsy. After studying at Oxford, he faced a significant professional and personal low when pursuing his PhD at Cambridge. Struggling with a difficult project, he persevered by pivoting his research and finding resilience through peers, eventually returning to practicing clinical medicine and finding his calling in oncology due to its unique overlap of molecular biology and opportunities for deep patient connection.Seeking further opportunities, Dr Camidge moved to the United States to lead the lung cancer program at the University of Colorado School of Medicine. He became a pivotal figure in the development of targeted therapies, specifically crizotinib for ALK-positive lung cancer. Beyond drug development, he championed the use of molecular profiling and established a global remote second opinion program.In 2022, Dr Camidge's perspective shifted profoundly following his own lung cancer diagnosis. This experience forced him to evolve from a "questioning machine" into someone more amenable to accepting love and support. He now integrates this dual perspective into his work, emphasizing that oncology must go beyond science to address the human experience of treating real people.
Tracing a trajectory from her medical education in China through a masters degree and PhD in Japan and a fellowship at the National Cancer Institute, Lifang Hou, MD, PhD, has cultivated an international career which now includes spearheading global cancer prevention initiatives that span from Africa to South America. In this episode, she discusses her career journey and how her work in genetics, epigenetics, and early cancer detection is helping bring affordable screening and prevention strategies to underserved communities around the world.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Small Cell Lung Cancer | Faculty Presentation 2: Management of Relapsed/Refractory SCLC; Promising Investigational Agents and Strategies — Christine L Hann, MD, PhD CME information and select publications
World Blood Donor Day is on Saturday, June 14th and in our islands, Blood Bank of Hawaii reminds all that every day is Blood Donor Day. Dr. Kim-Anh Nguyen [President and CEO, Blood Bank of Hawaii] talks on the importance of becoming a blood donor and knowing your blood type. She reminds us of neighbors, co-workers, family, and friends – even ourselves – who may one day count on the donation of blood. BBH's new Kapolei headquarters will soon offer an additional permanent donor station [along with their Young Street in McCully and Waikele Center locations] as well as career pathways for future phlebotomists. Kathy With a K is your host. "Hawaii Matters", a public service community program that airs on Sundays at 6:30 a.m. Hawaii across Pacific Media Group Oahu radio stations:KDDB 102.7 Da Bomb | KQMQ HI93 | KUMU 94.7 KUMU | KPOI 105.9 The WaveTo be featured or for inquiries on "Hawaii Matters", please email: kathywithak@1059thewavefm.comRecorded on June 2, 2026 at Pacific Media Group Oahu, Honolulu, HI 96813
Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge
Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer
Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer
Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge
Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge
Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer
Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer
In this episode of Precision and Progress: Radiotherapy in Oncology, hosts Hirsch Matani, MD, and Elizabeth Zhang-Velten, MD, PhD, welcomed Binh T. Ngo, MD, to discuss the evolving role of radiation, systemic therapy, and multidisciplinary care for patients with melanoma and other skin cancers.Dr Matani is a clinical assistant professor of radiation oncology at the Keck School of Medicine of the University of Southern California (USC) and a radiation oncologist at the USC Norris Comprehensive Cancer Center. Dr Zhang-Velten is a radiation oncologist and a clinical assistant professor with Keck Medicine of USC. Dr Ngo is an assistant professor of dermatology at Keck Medicine of USC.In their discussion, Drs Matani, Zhang-Velten, and Ngo broke down how surgical approaches, radiation, and systemic therapy all play roles in the treatment of patients with skin cancer. Dr Ngo highlighted key prevention strategies that patients should be advised on, along with recommended follow-ups for patients who are at higher risk or those who underwent prior solid organ or hematologic transplants.The trio also discussed how the use of radiation for patients with skin cancer varies from techniques used for patients with tumors located within deeper organs, and they also highlighted how radiotherapy approaches could be applied for patients with tumors that would be difficult to surgically resect.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NJM865. CME/MOC/AAPA/IPCE credit will be available until May 28, 2027.ReiNForcing Care Pathways in NF1-PN: Solutions to Improve Outcomes Across the Patient Journey With MEK Inhibition and Shared-Care Models In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Neurofibromatosis Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Alexion, AstraZeneca Rare Disease and SpringWorks Therapeutics, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NJM865. CME/MOC/AAPA/IPCE credit will be available until May 28, 2027.ReiNForcing Care Pathways in NF1-PN: Solutions to Improve Outcomes Across the Patient Journey With MEK Inhibition and Shared-Care Models In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Neurofibromatosis Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Alexion, AstraZeneca Rare Disease and SpringWorks Therapeutics, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NJM865. CME/MOC/AAPA/IPCE credit will be available until May 28, 2027.ReiNForcing Care Pathways in NF1-PN: Solutions to Improve Outcomes Across the Patient Journey With MEK Inhibition and Shared-Care Models In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Neurofibromatosis Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Alexion, AstraZeneca Rare Disease and SpringWorks Therapeutics, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
PeerView Neuroscience & Psychiatry CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NJM865. CME/MOC/AAPA/IPCE credit will be available until May 28, 2027.ReiNForcing Care Pathways in NF1-PN: Solutions to Improve Outcomes Across the Patient Journey With MEK Inhibition and Shared-Care Models In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Neurofibromatosis Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Alexion, AstraZeneca Rare Disease and SpringWorks Therapeutics, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NJM865. CME/MOC/AAPA/IPCE credit will be available until May 28, 2027.ReiNForcing Care Pathways in NF1-PN: Solutions to Improve Outcomes Across the Patient Journey With MEK Inhibition and Shared-Care Models In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Neurofibromatosis Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Alexion, AstraZeneca Rare Disease and SpringWorks Therapeutics, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NJM865. CME/MOC/AAPA/IPCE credit will be available until May 28, 2027.ReiNForcing Care Pathways in NF1-PN: Solutions to Improve Outcomes Across the Patient Journey With MEK Inhibition and Shared-Care Models In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Neurofibromatosis Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Alexion, AstraZeneca Rare Disease and SpringWorks Therapeutics, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PGK865. CME/AAPA/IPCE credit will be available until May 20, 2027.Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Karen L. Reckamp, MD, director of Medical Oncology, associate director of Clinical Research, and the medical oncology director of the Lung Institute at Cedars Sinai in Los Angeles, California.Drs Camidge and Reckamp discussed Dr Reckamp's journey as an oncology specialist and now a caregiver for her husband, who has cancer. Reckamp's career was inspired by her family's history with BRCA-related cancers. She pursued an academic path that eventually led her to Los Angeles, where she became a leader in thoracic oncology during an era of genomic breakthroughs.In late 2024, her husband, a fellow oncologist, was diagnosed with pancreatic cancer shortly after a clear annual scan. Reckamp described the jarring transition of receiving the diagnosis and the ensuing emotions balanced with medical pragmatism. Bob underwent intensive treatments that have affected his physical health and daily life.Reckamp offered a candid look at the dual role of a physician-caregiver. She continues to work, however, her husband's cancer diagnosis has changed her practice. Now, she is more sensitive to chemotherapy toxicities in her patients that she might have previously minimized. She also highlighted the invisible load of caregivers who must manage their own emotions and remain available for patient needs.Ultimately, Reckamp emphasized the necessity of a support network, crediting their long-time nanny and overall community with maintaining her family's stability. By allowing different people to hold different pieces of the emotional burden, Reckamp shared that her family is finding a way to move forward amidst the uncertainty of this cancer diagnosis.
Trisha Wise-Draper, MD, PhD - Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck Cancer
Trisha Wise-Draper, MD, PhD - Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck Cancer
Trisha Wise-Draper, MD, PhD - Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck Cancer
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/UXF865. CME credit will be available until June 7, 2027.RSV Prevention in Infants and Young Children: Empowering Pediatric NPs to Lead Early Protection In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/UXF865. CME credit will be available until June 7, 2027.RSV Prevention in Infants and Young Children: Empowering Pediatric NPs to Lead Early Protection In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/UXF865. CME credit will be available until June 7, 2027.RSV Prevention in Infants and Young Children: Empowering Pediatric NPs to Lead Early Protection In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
In this episode, we talk with Dr. Nicholas Theodosakis, MD, PhD. Dr. Theodosakis is a physician scientist at Massachusetts General Hospital who completed his MD/PhD at Yale School of Medicine before going on to pursue a combined dermatology residency and research fellowship at the Harvard Combined Dermatology Residency Program. Today, Dr. Theodosakis tells us about his path to dermatology, what it looks like to have a career as a physician scientist and interesting recent findings from his lab that impact our understanding of the skin. Dr. Theodosakis also discusses opportunities for students to work in his research lab. We wrap up with general advice for students interested in research as well as building an application for the field of dermatology. We hope you enjoy!If you enjoyed this episode, please share it with other students interested in dermatology!Learn More:Educational links: Dr. Theodosakis research: https://pubmed.ncbi.nlm.nih.gov/41446198/Email: NTHEODOSAKIS@MGH.HARVARD.EDU---DIGA Instagram: @derminterestToday's Host, George: @georgepapadeas---For questions, comments, or future episode suggestions, please reach out to us via email at derminterestpod@gmail.com ---District Four by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/3662-district-four**License: https://filmmusic.io/standard-license**---
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/UXF865. CME credit will be available until June 7, 2027.RSV Prevention in Infants and Young Children: Empowering Pediatric NPs to Lead Early Protection In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/UXF865. CME credit will be available until June 7, 2027.RSV Prevention in Infants and Young Children: Empowering Pediatric NPs to Lead Early Protection In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia | Faculty Presentation 1: Role of Bruton Tyrosine Kinase (BTK) Inhibitors in Newly Diagnosed and Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) — Wojciech Jurczak MD, PhD CME information and select publications
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia | Faculty Presentation 2: Emerging BTK Inhibitor-Based Combination Approaches in CLL — Jennifer R Brown MD, PhD CME information and select publications
Companies and institutions have mission statements, but when it comes to individuals, it is unfortunately much less common. Maybe it's time to change that narrative. Crafting a personal mission statement takes strategic planning. This means being deliberate about having your behavior reflect what drives you. It entails reflecting on what is important to you and what values should govern your decision making as you forge ahead in your career. Luckily for us, Adam D. Wolfe, MD, PhD, makes his fourth appearance on the Faculty Factory Podcast this week to discuss just that. Everyone wants to save time, and there may not be a better time saver than doing what Dr. Wolfe encourages, which is to revisit your values, personal mission statement and what you want to accomplish in the next year or two. That true north will help you have the confidence to say no, and a well-timed "no," as many of us can painfully attest, can save you significant time, headaches, and stress. About Dr. Wolfe Dr. Wolfe is Associate Professor of Pediatrics and Program Director of the Pediatric Residency Program. He also serves as Assistant Dean of Medical Education and holds the Jann L. Harrison Endowed Chair in Pediatric Graduate Medical Education at Baylor College of Medicine in San Antonio at CHRISTUS Children's. As mentioned, this is Dr. Wolfe's fourth appearance on the Faculty Factory Podcast. Please be sure to visit his previous appearances here: Visit episode 320 – Self-Promotion and Other Challenges to Embrace in Academic Medicine Check out episode 326 – Key Communication Tips for Better Relationships in Academic Medicine Here is episode 374 - The Power of Peer Mentoring Circles
Riley Behan-Bush found the MD/PhD program through a Google search. Hannah Van Ert had already started a career in nursing before a research lab changed her path completely. Eight years (!) of combined medical and scientist training later, they're in their final stretch — and it often didn't feel like a long slog of schooling. They sit down with MSTP faculty Darren Hoffman, PhD, and Martha Carvour, MD/PhD (CCOM Class of 2012) to talk about how it works, what this path actually costs, who gets access to it, and whether federal funding cuts are about to make it a lot harder to find out.
In today's episode, we welcomed Pedram Razavi, MD, PhD, and Dara S. Ross, MD. Dr Razavi is a breast medical oncologist and director of Liquid Biopsy & Genomics at Memorial Sloan Kettering Cancer Center in New York, New York. Dr Ross is an associate attending pathologist at Memorial Sloan Kettering Cancer Center.In our exclusive interview, Drs Razavi and Ross discussed the evolution of ESR1 mutation–directed breast cancer management, emphasizing the role of comprehensive genomic testing at metastatic recurrence, including liquid biopsy and tissue sequencing. They highlighted that ESR1 mutations can develop in patients receiving aromatase inhibitors and that the detection of these mutations is crucial for treatment decisions. They also highlighted findings from the phase 3 SERENA-6 trial (NCT04964934), which tested switching to camizestrant upon the emergence of an ESR1 mutation during treatment with an aromatase inhibitor and a CDK4/6 inhibitor ahead of radiographic disease progression in patients with hormone receptor–positive, HER2-negative metastatic breast cancer. Despite concerns from the FDA's Oncologic Drugs Advisory Committee (ODAC) about SERENA-6's design and overall survival outcomes, the experts praised the trial's innovative approach to personalizing breast cancer management based on biomarkers and noted ways that the ODAC decision may affect future clinical research in this field.
Sven Francque, MD, PhD - The Gastroenterologist's Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday Practice
Recorded and published daily during #ASGCT2026, Soundbites of the Annual Meeting captures the energy and breadth of the conference through quick-hit conversations, scientific snapshots, attendee perspectives, and highlights from across the field — offering a daily pulse on what’s happening throughout the meeting. Take a listen from Thursday, May 14, 2026 as we talk with Defne Amado, MD, PhD, a 2026 ASGCT Career Development Award recipient. Dr. Amado discusses her research in therapies for ALS and discusses what she’s excited about in the field. This soundbite is hosted by Widler Casy, PhD, of the ASGCT Communications Committee. Music: Everything Connected by High Street Music.Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.
Recorded and published daily during #ASGCT2026, Soundbites of the Annual Meeting captures the energy and breadth of the conference through quick-hit conversations, scientific snapshots, attendee perspectives, and highlights from across the field — offering a daily pulse on what’s happening throughout the meeting. Take a listen from Thursday, May 14, 2026 as we talk with Hans-Peter Kiem, MD, PhD, the 2026 recipient of the George Stamatoyannopoulos Mentorship Award. Dr. Kiem reflects on why receiving this award is so meaningful and also shares his thoughts on where the field of CGT is headed. This soundbite is hosted by Ben McLeod of the ASGCT Communications Committee. Music: Everything Connected by High Street Music.Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.
Food allergy diagnosis is still too often driven by tests instead of history, leading to unnecessary restriction and missed opportunities for targeted care. In this episode, we invite Dr. Anna Nowak-Wegrzyn, a leading researcher in food allergy and Director of Pediatric Allergy and Immunology Division at NYU Grossman School of Medicine, to help unpack the core clinical challenge of distinguishing true food allergy from sensitization, and discuss practical approaches to history-directed testing, component-resolved diagnostics, baked milk and egg tolerance, oral immunotherapy, and eosinophilic esophagitis recognition in atopic patients. We also highlight how primary care can help identify higher-risk patients earlier, improve referral decisions, and support more precise management using evolving diagnostic tools. For clinicians caring for children and adults with allergy, this conversation offers actionable insights for diagnosis, risk stratification, and day-to-day management. References and resources: https://www.thermofisher.com/phadia/us/en/resources/immunocast/eoe-food-allergy-diagnostics-update.html?cid=0ct_3pc_05032024_9SGOV4
How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Charles D. Blanke, MD, FACP, FASCO, a professor of medicine in the School of Medicine at the Oregon Health & Science University (OHSU) Knight Cancer Institute in Portland.Drs Camidge and Blanke discuss Dr Blanke's unique career path from pioneering targeted cancer therapies to becoming a leading advocate for medical aid in dying. A Type 1 diabetes diagnosis directed Dr Blanke toward an interest in internal medicine and oncology. During his fellowship and early faculty days, he established a reputation for his hard work pursuing research opportunities, even when initial projects were unsuccessful.Blanke's most transformative scientific achievement occurred at OHSU, where he spearheaded the use of Imatinib (Gleevec) for the management of gastrointestinal stromal tumor (GIST). By targeting the KIT mutation, this research turned a previously untreatable malignancy into one with a high response rate, marking a landmark moment for personalized oncology.Equally significant in Dr Blanke's career is his role in medical aid in dying. Practicing in Oregon, the first state to legalize the option, he has written hundreds of prescriptions for patients with terminal diseases. Blanke views medical aid in dying as a vital extension of patient care.As the former chair of SWOG, Dr Blanke modernized clinical research by introducing term limits, increasing access to clinical trials among, and championing the development of pragmatic trials with broader patient eligibility criteria. Throughout his tenure, he emphasized the importance of patient advocacy and the altruistic nature of cooperative research. Having recently stepped down from his leadership at SWOG, he intends to focus his future efforts on patient rights and medical aid in dying advocacy.
PeDRA President, Keith Choate, MD, PhD, shares his reflections on the Epidermal Differentiation Disorders Symposium!Learn more about Epidermal Differentiation Disorders.Join Jenn for an interview!
The evidence shows that vaginal birth after cesarean (VBAC) is a safe option for many families, but it's still frequently inaccessible to them. In this episode, Dr. Rebecca Dekker and Dr. Nicholas Rubashkin discuss the systemic barriers that limit families' opportunities to choose a VBAC. They explore how hospital policies, outdated guidelines, and clinical tools like the VBAC calculator have shaped who's a "good candidate" and who is not. Dr. Rubashkin also shares insights from his research on inequities in maternity care, including how race-adjusted algorithms reinforce disparities, why the "immediately available" standard still impacts hospital policies today, and how geography, provider practices, and induction policies can influence VBAC access. Plus, hear evidence-based strategies for advocating for a VBAC, including how to evaluate providers and interpret VBAC rates. (01:36) Dr. Rubashkin's background and path into obstetrics (08:32) Major barriers to VBAC access in the U.S. (11:37) The "immediately available" standard explained (14:38) Misconceptions about emergency cesarean availability (16:58) Ethical and legal implications of VBAC restrictions (18:02) Institutional barriers (20:17) The VBAC calculator and how it influenced access (26:12) Racism, bias, and interpretation of VBAC data (30:02) Induction and VBAC: evidence vs. practice (36:17) What informed consent for VBAC should include (37:18) Identifying supportive vs. reluctant providers Resources ACOG's VBAC guidelines and recommendations: acog.org/clinical/clinical-guidance/practice-bulletin/articles/2019/02/vaginal-birth-after-cesarean-delivery Human Rights in Childbirth: humanrightsinchildbirth.org/ UCSF's Better Birth Research Initiative: betterbirth.ucsf.edu/ International Cesarean Awareness Network: ican-online.org/ For more information about Evidence Based Birth® and a crash course on evidence based care, visit www.ebbirth.com. Follow us on Instagram and YouTube! Ready to learn more? Grab an EBB Podcast Listening Guide or read Dr. Dekker's book, "Babies Are Not Pizzas: They're Born, Not Delivered!" If you want to get involved at EBB, join our Professional membership (scholarship options available) and get on the wait list for our EBB Instructor program. Find an EBB Instructor here, and click here to learn more about the EBB Childbirth Class.
© 2020-2026 Ivy Podcast Discovery LLC
